Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Cambrex Adds R&D Lab for Generic APIs

June 13, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Cambrex expands its generic API research and development capabilities at its Milan, Italy site.

MilliporeSigma Opens Technical Support Center

June 08, 2018

MilliporeSigma targets emerging biotechs with US development center and global grants.

Anti-methamphetamine Antibody Moves to Clinic

June 01, 2018

Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.

Bosch Presents R&D Device for Continuous Oral Solid Dosage Production at Achema 2018

June 01, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Bosch Packaging Technology will introduce its newest R&D device for continuous oral solid dosage production at Achema 2018.

FUJIFILM Adds Late-Phase and Commercial Fill/Finish Capabilities

May 24, 2018

In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.

Cambrex Reports Expansions at its High Point, NC Facility

May 16, 2018

Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.

Catalent to Develop Biosimilars for Valerius Biopharma

May 16, 2018

Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.

Novartis’ Sandoz Receives CRL for Biosimilar to Roche’s Rituximab

May 08, 2018

The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.

GlobalData Reports on Humira Biosimilars Uptake in EU

May 07, 2018

The data and analytics company reports on the anticipated uptake of Humira (adalimumab)‎‎ biosimilars in the EU once they are launched in 2018.

Haselmeier, Common Sensing to Partner on Injectable Solutions

May 03, 2018

The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.